Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
The Phase 3 STOP-MD3 randomized controlled trial evaluated oral SPI-1005 against a placebo over a 4-week dosing period, with secondary follow-up endpoints measured at 12 weeks
Exfoliating periodically: remove the layer of dead cells on the surface, help the skin absorb nutrients better and maintain brightness smooth
Routine aspiration is no longer recommended by the WHO or CDC for the deltoid, ventrogluteal or vastus lateralis sites, as those sites carry negligible vessel risk
We can also guide you on pairing with topical treatments like tranexamic acid and niacinamide for maximum skin brightening
About this article Cite this article Honda, Y., Kessoku, T., Sumida, Y
US$ 21.71
US$ 23.72
US$ 20.91
US$ 25.19
